JAK2-STAT5, SRC-MAPK, and PI3K-AKT-mTOR) activated following GH/GHR binding in the TME signals induction of the EMT program, senescence, cancer stem cells, upregulation of multidrug efflux transporters, and downregulation of apoptosis [8]. The gene discussed is GH1; the disease is cancer.